论文部分内容阅读
目的:对比分析缓解期雾化吸入糖皮质激素的哮喘患者全科治疗及专科治疗的临床效果。方法:收集我院2012年10月至2013年10月期间缓解期雾化吸入糖皮质激素的哮喘患者66例作为研究对象,采用随机分组的方式将患者分为观察组与对照组,每组患者各33例。对照组采用专科治疗,观察组采用全科治疗,对两组患者的临床效果进行分析对比。结果:研究结果显示,观察组患者的临床症状评分为(1.1±0.3)分,对照组为(0.9±0.5)分,对照组评分略高于观察组,且对照组肺功能指标略好于观察组,但组间数据结果比较差异无统计学意义(P>0.05)。观察组患者全科组每周治疗费用为(159.24±25.14)元,对照组为(191.39±33.27)元,观察组的治疗费用明显低于对照组(P<0.05)。结论:缓解期雾化吸入糖皮质激素的哮喘患者全科治疗与专科治疗各具优势,专科治疗更有利于改善症状,全科治疗能减少经济负担,医治和随访更加方便。
OBJECTIVE: To compare and analyze the clinical effects of general treatment and specialist treatment of asthma patients who inhaled glucocorticoid in the remission period. Methods: Sixty-six asthmatic patients with nebulized inhaled corticosteroids in our hospital from October 2012 to October 2013 were collected. Patients were divided into observation group and control group by random grouping. Patients in each group 33 cases in each. Control group using specialist treatment, observation group with general treatment, the clinical effect of two groups of patients were analyzed and compared. Results: The results showed that the clinical symptom score of observation group was (1.1 ± 0.3) points, the control group was (0.9 ± 0.5) points, the control group score slightly higher than the observation group, and the control group slightly better than the observation of lung function Group, but there was no significant difference between groups (P> 0.05). The treatment cost of the general group was (159.24 ± 25.14) yuan in the observation group and (191.39 ± 33.27) yuan in the control group. The treatment cost in the observation group was significantly lower than that in the control group (P <0.05). Conclusion: The generalized and specialized treatment of inhaled glucocorticosteroid asthma patients in the remission period have their own advantages. Specialized treatment is more conducive to the improvement of symptoms. General treatment can reduce the economic burden, and it is more convenient for treatment and follow-up.